Matthew K. Fust - Nov 4, 2021 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
Director
Signature
/s/ David Tucker, Attorney-in-Fact
Stock symbol
ATRA
Transactions as of
Nov 4, 2021
Transactions value $
-$260,403
Form type
4
Date filed
11/5/2021, 04:28 PM
Previous filing
Nov 3, 2021
Next filing
Mar 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Sale -$260K -13.4K -29.77% $19.50 31.5K Nov 4, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction pursuant to Rule 10b5-1 Plan adopted May 14, 2021.